Burden of Respiratory Illnesses in Pediatric Intensive Care Unit and Predictors of Mortality

Sponsor
Sohag University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05691127
Collaborator
(none)
150
1
12
12.5

Study Details

Study Description

Brief Summary

Acute respiratory infections (ARI) are an important cause of mortality and morbidity among children; one-fifths of under-five mortality being contributed by them (predominantly pneumonias ).

About 11.9 million episodes of severe and 3.0 million episodes of very severe acute lower respiratory infections (ALRI) result in hospital admissions in young children worldwide.

Respiratory infections and illnesses in children thus form a substantial disease burden in Pediatric intensive care unit. With this is mind, we studied clinical profile and risk factors contributing to mortality, and outcome of children with acute respiratory infections.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Complete blood count (CBC), C reactive protein (CRP(., Chest x ray, ABG, Electrolytes, Random blood sugar, Creatinine, Coagulation profile

Study Design

Study Type:
Observational
Anticipated Enrollment :
150 participants
Observational Model:
Case-Control
Time Perspective:
Prospective
Official Title:
Burden of Respiratory Illnesses in Pediatric Intensive Care Unit and Predictors of Mortality
Anticipated Study Start Date :
Jan 1, 2023
Anticipated Primary Completion Date :
Jan 1, 2024
Anticipated Study Completion Date :
Jan 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Respiratory Diseased children

Diagnostic Test: Complete blood count (CBC), C reactive protein (CRP(., Chest x ray, ABG, Electrolytes, Random blood sugar, Creatinine, Coagulation profile
I will use these investigations in my study

Outcome Measures

Primary Outcome Measures

  1. incidence of respiratory illnesses [one year]

    incidence of respiratory illnesses in PICU among other children

Eligibility Criteria

Criteria

Ages Eligible for Study:
1 Month to 12 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:

Children with pneumonia, bronchiolitis, bronchial asthma, chemical pneumonitis, cystic fibrosis and other respiratory diseases, Cardiorespiratory cases and Neurological cases with respiratory illness

Exclusion Criteria:

Post trauma case. Postoperative cases (developing respiratory complications during PICU stay).

Contacts and Locations

Locations

Site City State Country Postal Code
1 Sohag University Hospital Sohag Egypt

Sponsors and Collaborators

  • Sohag University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Hadier Khaled Mahmoud, resident at pediatric departement at el helal hospital, Sohag University
ClinicalTrials.gov Identifier:
NCT05691127
Other Study ID Numbers:
  • soh-Med-22-12-08
First Posted:
Jan 19, 2023
Last Update Posted:
Jan 19, 2023
Last Verified:
Jan 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Jan 19, 2023